The VTE event in patients with psoriasis (A), atopic dermatitis (B), alopecia areata (C), vitiligo (D), hidradenitis suppurativa (E), and overall CISD (F) was defined as inpatient- or outpatient-diagnosed VTE with evidence of treatment after 1:1 propensity-score matching. Dark lines within the graphs represent 95% CIs.